Description and Brand Names
Información sobre medicamentos proporcionada por: IBM Micromedex
US Brand Name
- Vyxeos
Descriptions
Daunorubicin and cytarabine injection is used to treat therapy-related acute myeloid leukemia (AML) or AML with myelodysplasia-related changes (AML-MRC).
Daunorubicin and cytarabine liposome interferes with the growth of cancer cells, which are eventually destroyed by the body. Since the growth of normal body cells may also be affected by doxorubicin and cytarabine liposome, other unwanted side effects will also occur. Some of these may be serious and must be reported to your doctor.
This medicine is to be given only by or under the supervision of your doctor.
This product is available in the following dosage forms:
Portions of this document last updated: Aug. 01, 2020
Copyright © 2020 IBM Watson Health. Todos los derechos reservados. La información es para uso exclusivo del usuario final y no puede venderse, redistribuirse ni utilizarse de ninguna otra forma con fines comerciales.